Viewing Study NCT05993858


Ignite Creation Date: 2025-12-25 @ 12:18 AM
Ignite Modification Date: 2026-05-28 @ 3:55 PM
Study NCT ID: NCT05993858
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-08-15
First Post: 2023-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Squamous Cell Carcinoma View
None Neoadjuvant Therapy View
Keywords: